Cargando…

Colchicine Against SARS-CoV-2 Infection: What is the Evidence?

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of concern worldwide and a huge challenge for rheumatologists. Indeed, several antirheumatic drugs are currently used at different stages of COVID-19, such as several cytokine i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drosos, Alexandros A., Pelechas, Eleftherios, Drossou, Vassiliki, Voulgari, Paraskevi V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808271/ https://www.ncbi.nlm.nih.gov/pubmed/35107804 http://dx.doi.org/10.1007/s40744-022-00425-0

Ejemplares similares

A Response to: Letter to the Editor Regarding the Article: “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
por: Drosos, Alexandros A., et al.
Publicado: (2022)

COVID-19 in patients with gout on colchicine
por: Pelechas, Eleftherios, et al.
Publicado: (2021)

Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence?
por: Pelechas, Eleftherios, et al.
Publicado: (2020)

Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients
por: Pelechas, Eleftherios, et al.
Publicado: (2022)

Seronegative Erosive Arthritis Following SARS-CoV-2 Infection
por: Drosos, Alexandros A., et al.
Publicado: (2021)

Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience
por: Migkos, Michalis P., et al.
Publicado: (2021)

Rheumatoid Arthritis Treatment. A Back to the Drawing Board Project or High Expectations for Low Unmet Needs?
por: Drosos, Alexandros A., et al.
Publicado: (2019)

Golimumab for Rheumatoid Arthritis
por: Pelechas, Eleftherios, et al.
Publicado: (2019)

Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis
por: Pelechas, Eleftherios, et al.
Publicado: (2019)

Long COVID from rheumatology perspective: a simple mimicker or promoter of autoimmunity?
por: Drosos, Alexandros A., et al.
Publicado: (2022)

A Patient with Symmetrical Polyarthritis. The Value of Conventional Radiography for a Correct Diagnosis
por: Drosos, Alexandros A., et al.
Publicado: (2022)

Treatment strategies of COVID-19: A rheumatology perspective
por: Drosos, Alexandros A., et al.
Publicado: (2022)

A Case of Recalcitrant Psoriatic Arthritis to TNF Inhibitors Improved After Administration of Secukinumab, an IL-17A Inhibitor
por: Pelechas, Eleftherios, et al.
Publicado: (2017)

Maintained Clinical Remission in Ankylosing Spondylitis Patients Switched from Reference Infliximab to Its Biosimilar: An 18-Month Comparative Open-Label Study
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2019)

An uncommon presentation of Granulomatosis with Polyangiitis
por: Pelechas, Eleftherios, et al.
Publicado: (2018)

A not-to-miss Cause of Severe Cervical Spine Pain in a Patient with Rheumatoid Arthritis: A Case-Based Review
por: Drosos, Alexandros A., et al.
Publicado: (2021)

Comment on the Article “Adalimumab-Induced Lupus Nephritis: Case Report and Review of the Literature”
por: Drosos, Alexandros A., et al.
Publicado: (2023)

Biologic Therapies and Autoimmune Phenomena
por: Drosos, Alexandros A., et al.
Publicado: (2021)

Letter to the Editor Regarding “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
por: Finsterer, Josef
Publicado: (2022)

The impact of temporal artery biopsy for the diagnosis of giant cell arteritis in clinical practice in a tertiary university hospital
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2019)

Dermatomyositis sine myositis – Case presentation
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2017)

Colchicine and SARS-CoV-2: Management of the hyperinflammatory state
por: Vitiello, Antonio, et al.
Publicado: (2021)

Long-term use of adalimumab in the treatment of rheumatic diseases
por: Papagoras, Charalampos, et al.
Publicado: (2009)

Fasting mimicking diets: A literature review of their impact on inflammatory arthritis
por: Venetsanopoulou, Aliki I., et al.
Publicado: (2019)

SARS‐CoV‐2 and human milk: What is the evidence?
por: Lackey, Kimberly A., et al.
Publicado: (2020)

SARS-CoV-2 and human milk: what is the evidence?
por: Lackey, Kimberly A., et al.
Publicado: (2020)

The usefulness of magnetic resonance imaging of the hand and wrist in very early rheumatoid arthritis
por: Kosta, Paraskevi E, et al.
Publicado: (2011)

A Rare Case of Acute Pericarditis Due to SARS-CoV-2 Managed With Aspirin and Colchicine
por: Thrupthi, Komandur, et al.
Publicado: (2021)

SARS‐CoV‐2 infection and cancer: Evidence for and against a role of SARS‐CoV‐2 in cancer onset
por: Stingi, Aureliano, et al.
Publicado: (2021)

A Conversation Between Two Viruses: SARS-CoV and SARS-CoV-2 — Based on a True Story
por: Diamandis, Eleftherios P.
Publicado: (2020)

Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far
por: Alsafi, Radi Taha
Publicado: (2022)

Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2014)

Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences
por: Campione, Elena, et al.
Publicado: (2021)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

HIV and SARS-CoV-2 Co-Infection: What are the Risks?
por: Squillace, Nicola, et al.
Publicado: (2021)

Sjögren Syndrome Associated with Inflammatory Muscle Diseases
por: Migkos, Michail P., et al.
Publicado: (2018)

Evidence for Gastrointestinal Infection of SARS-CoV-2
por: Xiao, Fei, et al.
Publicado: (2020)

COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2022)

What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?
por: Martinez, Miguel Angel
Publicado: (2022)

Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
por: Gendelman, Omer, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hi92qh2e3b4ojethl51p186gkd